Skila KOL Experts Featured in Pharmaceutical Executive Europe

PRLog (Press Release) – Nov 14, 2007 – Skila, A Sela2 Company, conveys it’s experience and recommendations in managing key opinion leaders in a recent article entitled: “Going Global: A Paradigm Shift in KOL Management.” The article, which appears in the October 2007 issue of Pharmaceutical Executive Europe, describes new trends and depicts a holistic approach to Key Opinion Leader Management.

Realizing that today’s fast-paced global business environment mandates coordination and transparency when it comes to managing KOL relationships, Skila’s experts in Key Opinion Leader Management, Simon Mason, Jillian Lin and Karen Keneflick-Massand, have truly revolutionized the way in which life science companies handle KOL Management. According to Skila’s experts, “The evolution of a truly global strategic approach to KOL relationships demands a certain paradigm shift from focusing solely on building external relationships on an activity-centred basis to understanding the consequence of not having a well defined, internal process and capability in place to tie activities to strategic initiatives across the entire global organization.”

The authors discuss these new trends and common hurdles in the implementation of KOL programs in a global organization that touches opinion leaders in many different ways. The article also describes the 6 Tenets of KOL Management and focuses on how important this methodology is when compliance with different regulatory bodies on a worldwide basis is critical to the brand’s success.

The “Going Global: A Paradigm Shift in KOL Management” article is available online at: http://www.pharmexeceurope.com/europharmexec/Articles%3A ...


About Skila
For over 12 years Skila has been recognized as a global leader in delivering global sales and marketing effectiveness solutions and platforms to pharmaceutical and biotechnology companies world-wide. Skila’s single touch-point solutions foster multi-way communication and the sharing of best practices, while incorporating built-in actions that augment world-wide collaboration and drive more coordinated management of global brand resources, assets and best practices.

With a unique blend of expert business advisory, proven business process methodologies, innovative pull through services, and our proprietary Intelligration® technology, Skila’s solutions have helped teams around the globe to identify, gather, present and distribute actionable knowledge - while compiling a fluid map of who knows what within the global organization. Skila’s solutions have been adopted by many of the leading companies in the industry, including: Boehringer Ingelheim, Roche, Eli Lilly & Company, Allergan and Gilead. To date, our solutions have helped facilitate:
•   Over Ten Million user interactions
•   In 56 countries
•   Across 11 therapeutic categories
•   For more then 30 brands

While other marketing effectiveness approaches offer clients either consultative services or technology that must be owned and managed solely by internal teams in order to remain operational, Skila’s full-service solutions use a proven blend of web-based technology, methodology and on-going support to ensure results.

Skila’s managed solutions:
•   Help life science organizations realize strategic goals by operationalizing strategy into actionable, manageable and measurable tasks
•   Empower teams to access, share, collaborate, enhance, optimize and maximize the efficacy and efficiency of their marketing efforts locally, regionally, and across the global enterprise
•   Ensure on-going relevance, support and usage
•   Enable the creation, adoption and dissemination of best practices
•   Provide rapid access to timely, critical information
•   Assess and manage performance, while adjusting tactics accordingly
•   Are relied on and valued by Pharmaceutical companies and brands world-wide.

To learn more about Skila visit our website at www.skila.com.